51勛圖厙

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinsons, glioblastoma and dementia

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Open Science project funded for $1.5M

Published: 12 November 2024

YCharOS antibody characterization platform addresses the reproducibility crisis in research...

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Latest Alzheimers drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimers-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasones impact on brain cancer immunotherapy...

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

SCSD Research Day

Published: 10 February 2025

Friday February 21st 2025 3pm to 5pm Leacock Building #232, 855 Sherbrooke West

Pages

Back to top